PROTECT YOUR WORKPLACE AND KEEP YOUR TEAM SAFE.
We offer customized covid-19 testing for your workplace. It is important to keep your workplace safe for both your employees and your clients. We bring a customized experience to you so that you can keep doing what you do best.
Don’t wait until COVID-19 impacts your business. Multicare Plus delivers accurate diagnostic results to meet your business testing needs. Our COVID-19 testing options include the following:
- Testing with same day results
- Nasopharyngeal swabs
- Telehealth consultations
We Provide Access to Testing
Reduce Asymptomatic Exposure and Spread
PCR testing helps identify the presence of virus within the body. We supply testing solutions to test your employees. All of our COVID-19 testing is done through nasal swabs with 98% sensitivity and 100% specificity. Results are all read and delivered by healthcare professionals within the same day.
Get results in one hour
Rapid PCR testing is a technique in which the surface proteins of the virus are tested with much faster response. Results are reliable and 98% accurate. We can provide drive through testing to decrease exposure.
Concierge Flu Vaccine
Get your employees vaccinated today!
Multicare Plus is now offering on-site influenza vaccines for your employees. Influenza vaccines will be more important than ever this season as many who get the flu will be unsure if they are infected with SARS-CoV-2. This could lead to unwanted call outs and decreased productivity. We are here to help. Call our office for pricing and availability.
We Make COVID-19 Business Testing Easy
We customize testing for your business, catering to small businesses and large corporations. We take the burden off management and human resources that may struggle to organize employee testing. We handle all the details to make the process effective and safe from start to finish.
All testing is performed by qualified medical professionals that are highly trained, ensuring that each COVID-19 test is administered with an unmatched level of accuracy. Each test is FDA and EUA approved to meet our clients’ demand. Our fast turnaround times include 45-minute PCR results. We can provide results to the employer the same day as testing so employees can get back to work sooner.
No Matter the Industry, We have the Covid-19 Testing Solutions For Your Needs
HOW IT’S DONE!
The Respiratory Panel
SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The Viral Panel (EUA) is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.
1 Test. 22 Targets. ~45 Minutes.
The Covid Panel (EUA) uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. Fast and comprehensive, the Viral Panel (EUA) offers a run time of about 45 minutes, enabling high efficiency. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients. Quick turnaround on a broad menu of pathogens may also help clinicians make vital decisions regarding admission, isolation, cohorting, and additional diagnostic testing.
RESPIRATORY 2.1 PANEL (EUA) MENU
Overall 97.1% sensitivity and 99.3% specificity (prospective specimens) 3
SARS-CoV-2 98.0% sensitivity and 100% specificity (archived specimens)4
SARS-CoV-2 100% PPA and 100% NPA (contrived specimens)5
Sample Type: Nasopharyngeal swab in transport media
● Coronavirus HKU1
● Coronavirus NL63
● Coronavirus 229E
● Coronavirus OC43
● Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
● Human Metapneumovirus
● Human Rhinovirus/Enterovirus
● Influenza A
● Influenza A/H1
● Influenza A/H3
● Influenza A/H1-2009
● Influenza B
● Parainfluenza Virus 1
● Parainfluenza Virus 2
● Parainfluenza Virus 3
● Parainfluenza Virus 4
● Respiratory Syncytial Virus
● Bordetella parapertussis
● Bordetella pertussis
● Chlamydia pneumoniae
● Mycoplasma pneumoniae
COVID-19 and the Value of the Syndromic Approach
Study results suggest higher rates of co-infection between SARS-CoV-2 and other respiratory pathogens than previously reported. In some cases, as many as 20% of COVID-19 patients have co-infections with another respiratory virus.6 Because respiratory symptoms are similar and overlapping, a syndromic panel can provide fast, comprehensive answers and take the guesswork out of choosing which pathogens to test for.